Tenofovir disoproxil fumarate placebo

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV InfectionHIV Infections

Phase 2

Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women

CompletedNCT00705679

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2009-08-31End: 2012-08-31Updated: 2021-10-29

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

CompletedNCT01505114

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infection

Start: 2012-06-30End: 2015-11-30Updated: 2021-11-05

Unknown Phase

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

CompletedNCT00729573

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2009-11-30End: 2013-05-31Updated: 2023-02-08

Related Papers

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305

PLoS ONE2018-12-264 citations

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

2017-08-2228 citations

Sharing of Investigational Drug Among Participants in the Voice Trial.

2016-11-012 citations

PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)

The Journal of Infectious Diseases2016-10-3147 citations

Stated product formulation preferences for HIV pre‐exposure prophylaxis among women in the VOICE‐D (MTN‐003D) study

Journal of the International AIDS Society2016-01-0184 citations

Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN‐003 (VOICE) study

Journal of the International AIDS Society2016-01-0152 citations

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

2015-07-0143 citations

Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study

The Journal of Infectious Diseases2015-06-2943 citations

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

PLoS ONE2015-05-0557 citations

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

New England Journal of Medicine2015-02-041278 citations

A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.

2011-10-1987 citations